FZD8 anticorps (N-Term)

N° du produit ABIN502083

Détail du produit anti-FZD8 anticorps

Antigène: FZD8 (Frizzled Family Receptor 8 (FZD8))

Épitope: N-Term

Reactivité: Humain, Souris, Rat, Chien

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FZD8 est non-conjugé

Application: Western Blotting (WB)

Séquence: PDTLCMDYNR TDLTTAAPSP PRRLPPPPPG EQPPSGSGHG RPPGARPPHR

Homologie: Dog: 100%, Human: 100%, Mouse: 93%, Rat: 92%

Attributs du produit: This is a rabbit polyclonal antibody against FZD8. It was validated on Western Blot using a cell lysate as a positive control.

Purification: Affinity Purified

Immunogène: The immunogen is a synthetic peptide directed towards the N terminal region of human FZD8

Information d'application

Indications d'application: Optimal working dilutions should be determined experimentally by the investigator.

Commentaires:

Antigen size: 694 AA

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze-thaw cycles.

Stock: -20 °C

Stockage commentaire: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Références pour anticorps anti-FZD8 (ABIN502083)

Xu, Wen, Liu, Xu, Yang, Liu, Feng, An: "MicroRNA-375 suppresses human colorectal cancer metastasis by targeting Frizzled 8." dans: Oncotarget, Vol. 7, Issue 26, pp. 40644-40656, (2016) (PubMed).

Yin, Xu, Bonfil, Banerjee, Sarkar, Sethi, Reddy: "Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer." dans: Molecular cancer therapeutics, Vol. 12, Issue 4, pp. 491-8, (2013) (PubMed).

Détails sur FZD8

Antigène: FZD8 (Frizzled Family Receptor 8 (FZD8))

Autre désignation: FZD8 (FZD8 Produits)

Synonymes: anticorps FZ-8, anticorps hFZ8, anticorps FZD8, anticorps Fz-8, anticorps frizzled8, anticorps xfz8, anticorps Xfz8, anticorps frizzled-8, anticorps hfz8, anticorps Fz8, anticorps fzd8, anticorps fz5, anticorps fz8a, anticorps fzc, anticorps wu:fd02c05, anticorps zg05, anticorps ZG06, anticorps Zfz8b, anticorps fz6, anticorps fz8b, anticorps fzA, anticorps ik:tdsubc_1e1, anticorps xx:tdsubc_1e1, anticorps zfzA, anticorps frizzled class receptor 8, anticorps frizzled class receptor 8 S homeolog, anticorps frizzled class receptor 8 L homeolog, anticorps frizzled class receptor 8a, anticorps frizzled class receptor 8b, anticorps FZD8, anticorps fzd8.S, anticorps fzd8, anticorps Fzd8, anticorps fzd8.L, anticorps fzd8a, anticorps fzd8b

Sujet: FZD8 is a member of the frizzled family. Members of this family are seven-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. This protein is highly expressed in two human cancer cell lines, indicating that it may play a role in several types of cancer. The crystal structure of the extracellular cysteine-rich domain of a similar mouse protein has been determined.This intronless gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. This gene is highly expressed in two human cancer cell lines, indicating that it may play a role in several types of cancer. The crystal structure of the extracellular cysteine-rich domain of a similar mouse protein has been determined.
Alias Symbols: FZ-8, hFZ8
Protein Interaction Partner: WNT1, LRP5, LRP6, SUMO1, GOPC, RYK,
Protein Size: 694

Poids moléculaire: 73 kDa

ID gène: 8325

NCBI Accession: NM_031866, NP_114072

UniProt: Q9H461

Pathways: Signalisation WNT